Pursuant to Regulation 30(6) of Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that it enclosed the link for video recording & transcript link uploaded on the website at https://india-pharma.gsk.com/enin/investors/analyst-meets/ of the Analyst / Institutional Meeting held on 13th May 2025.
The above information is a part of company’s filings submitted to BSE.